Heparanase inhibitory peptides and use thereof for treating clinical pathologies
US10105410B2 · kind B2 · utility
0Cited by
0References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 9, 2015 |
| Grant date | Oct 23, 2018 |
| Priority date | — |
| Expiry date | Mar 9, 2035 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P15/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is directed to peptides derived from certain domains of tissue factor pathway inhibitor (TFPI) for use in the treatment of solid tumors and diseases or disorders associated with abnormal clotting.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.